Cardiovascular devices are medical devices used to diagnose and treat cardiovascular diseases, which are conditions that affect the heart and blood vessels. These devices are critical for the treatment of patients with heart disease, as they can help improve heart function, reduce symptoms, and prevent complications. The cardiovascular devices market in Germany is likely to register a CAGR of over 5.4% with an incremental growth of USD 1.4 billion during the forecast period 2023-2029.
This industry report offers market estimates of the Germany market, followed by a detailed analysis of the product. The Germany market data on cardiovascular devices can be segmented by product: aortic and vascular graft devices, atherectomy devices, cardiac assist devices, cardiac rhythm management devices, cardiovascular prosthetic devices, cardiovascular surgery devices, clot management devices, electrophysiology devices, interventional cardiology, peripheral vascular devices, prosthetic heart valves. In 2022, the interventional cardiology segment made up the largest share of revenue generated by the cardiovascular devices market.
The Germany cardiovascular devices market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Abbott Laboratories, Abiomed Inc, B. Braun Melsungen AG, Biosense Webster Inc, Biotronik AG, Boston Scientific Corporation, C. R. Bard Inc., Cook Medical Inc, Edwards Lifesciences Corporation, Koninklijke Philips N.V., LivaNova PLC, MAQUET Holding B.V. & Co. KG, Medtronic Plc, MicroPort Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
▹ Get a detailed picture of the Germany Cardiovascular Devices Market
▹ Identify segments/areas to invest in over the forecast period in the Germany Cardiovascular Devices Market
▹ Understand the competitive environment, the market’s leading players
▹ The market estimate for ease of analysis across scenarios in Excel format.
▹ Strategy consulting and research support for three months.
▹ Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2022 |
| Forecast Year | 2023-2029 |
| CAGR (2023-2029) | 5.4% |
| Pages | 21 |
| Key Players | Abbott Laboratories, Abiomed Inc, B. Braun Melsungen AG, Biosense Webster Inc, Biotronik AG, Boston Scientific Corporation, C. R. Bard Inc., Cook Medical Inc, Edwards Lifesciences Corporation, Koninklijke Philips N.V., LivaNova PLC, MAQUET Holding B.V. & Co. KG, Medtronic Plc, MicroPort Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc. |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
